SOX2 and cancer: Other studies reported high frequencies of CD4+ and CD8+ T cells directed against some cancer/testis antigens or SOX-2 in MGUS patients, showing significant associations with a reduced risk of progression to MM, improved disease control, and longer survival [65,66,67,68].